Asymchem Laboratories (Tianjin) Co., Ltd.

Shenzhen Stock Exchange 002821.SZ

Asymchem Laboratories (Tianjin) Co., Ltd. Dividends Paid for the year ending December 31, 2023: USD -93.51 M

Asymchem Laboratories (Tianjin) Co., Ltd. Dividends Paid is USD -93.51 M for the year ending December 31, 2023, a -205.43% change year over year. Dividends paid is cash paid to shareholders as a distribution of profits.

Asymchem Laboratories (Tianjin) Co., Ltd. Dividends Paid for the year ending December 31, 2022 was USD -30.62 M, a -33.64% change year over year.
Asymchem Laboratories (Tianjin) Co., Ltd. Dividends Paid for the year ending December 31, 2021 was USD -22.91 M, a -29.31% change year over year.
Asymchem Laboratories (Tianjin) Co., Ltd. Dividends Paid for the year ending December 31, 2020 was USD -17.72 M, a -33.34% change year over year.
Asymchem Laboratories (Tianjin) Co., Ltd. Dividends Paid for the year ending December 31, 2019 was USD -13.29 M, a -13.47% change year over year.

Key data

Date	Dividends Paid	Capital Expenditure	Other Financing Activities	Net Cash Used Provided By Financing Activities

Shenzhen Stock Exchange: 002821.SZ

Asymchem Laboratories (Tianjin) Co., Ltd.

CEO	Dr. Hao Hong Ph.D.
IPO Date	Nov. 22, 2016
Location	China
Headquarters	No. 6 Dongting 3rd Street
Employees	9,788
Sector	Health Care
Industries Pharmaceuticals Biotechnology Chemicals & Advanced Materials

Description

Asymchem Laboratories (Tianjin) Co., Ltd. provides contract development and manufacturing organization services in Mainland China and internationally. The company offers drug research and development, and manufacturing services for pharmaceutical and biotech companies. Its solutions range from early clinical stage to commercial stage, including research and development, and cGMP production of advanced intermediates, active pharmaceutical ingredients, and formulations, as well as clinical research services. The company also engages in the provision of pharmaceutical analysis and testing services; sale, wholesale, and retail of drugs; and pharmaceutical science and technology development activities. The company was founded in 1999 and is headquartered in Tianjin, China.

Key trends

Past 5 years